Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Semaglutide

Research Study Investigating How Well Semaglutide Works in People From Thailand and South Korea Living With Obesity

Novo Nordisk · Phase 3 · Completed · Enrollment 150

NCT04998136

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

X axis: threshold category. Y axis: participants reaching threshold, %.

96129212
≥5%
≥10%
≥15%
≥20%
  • Semaglutide 2.4 mg
  • Placebo
  • Semaglutide, on treatment
  • Placebo, on treatment
Show as table
Arm≥5%≥10%≥15%≥20%
Semaglutide 2.4 mg96%n/rn/rn/r
Placebo12%n/rn/rn/r
Semaglutide, on treatment92%n/rn/rn/r
Placebo, on treatment12%n/rn/rn/r

Not shown

Every selected arm is drawn.